Five Dumbest Things

The Five Dumbest Things on Wall Street: May 14

Stock quotes in this article:C, FNM, FRE, NDAQ, NYX, BSX 

Boston Blackout

Be serious, Boston Scientific(BSX). Do you really think you can hide your stupidity from us?

The medical device maker, which has been a frequent visitor to our esteemed Dumbest list, barred media from its shareholders meeting this Wednesday. The company did not offer a reason for closing its doors to the press. Previous meetings have been open to everybody, including ink-stained wretches such as ourselves.

What a joke! We already knew about the company's $1.6 billion first-quarter loss. How on earth could they top that? Announce another defibrillator recall maybe? Or how about pay Johnson & Johnson(JNJ) another $1.7 billion over a patent dispute?

And speaking of multimillion dollar misfires, the annual meeting in Boston was the first since J. Raymond Elliott took over last July as president and chief executive. The company paid Elliott a cardiac arresting $33.5 million in total compensation in 2009, according to a regulatory filing, the largest payout to any business executive in the region last year.

If all it takes to make Elliott's heart stop is a few tough questions from a bunch of journalists, then he should be using heart devices -- not selling them.

Dumb-o-meter score: 90 -- Boston's dumb decisions are not-so-Scientific.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,454.83 1,317.82 2,837.53 17.45
Oil *
107.26
DOWN
74.92
DOWN
2.86
DOWN
1.85
DOWN
0.14
10 Yr
1.74%
SPDR Gold
152.68
-0.60%
-0.22%
-0.07%
-0.80%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet